- A new real-estate category is emerging among wealthy New York retirees: the “med-à-terre” — a second property kept or purchased specifically to maintain access to elite medical specialists at institutions like Memorial Sloan Kettering, Hospital for Special Surgery, and Mount Sinai.
- Buyers typically target $2–$5 million turnkey condos in Midtown, Sutton Place, and the Upper East Side — neighborhoods clustered near Manhattan’s top hospital corridors — with some spending up to $10 million for proximity and serviced-building convenience.
- The trend is being driven by pandemic-era relocators who discovered that while they can retire to Florida or elsewhere financially, they cannot replicate decades-long relationships with top-tier oncologists and cardiologists in their new home cities.
- New York State just passed a pied-à-terre tax on luxury second homes valued at $5 million or more — a potential headwind, but brokers say medical access is a powerful enough draw that the tax is unlikely to deter buyers whose primary motivation is healthcare continuity rather than lifestyle.
What Happened?
The Wall Street Journal profiles a growing cohort of affluent older New Yorkers who relocated during the pandemic — to Miami, the Sunbelt, or elsewhere — but are now buying second properties back in or near New York City specifically to preserve access to elite medical specialists. One couple, for example, bought a Jersey City loft as a staging base for quarterly checkups at Upper East Side specialists they’ve seen for decades, avoiding the burden of commuting from their Miami Beach primary home. Brokers at Compass, Coldwell Banker Warburg, and Sotheby’s International Realty all describe the pattern: buyers targeting $2M–$10M condos near hospital clusters, prioritizing concierge buildings and turnkey interiors over space or prestige. The phenomenon mirrors an older trend around the Mayo Clinic in Minnesota, where wealthy patients from across the country maintain luxury rentals or own properties specifically for medical access. A new New York State pied-à-terre tax, just passed Wednesday, targets second homes valued at $5 million or more — but brokers say the medical motivation makes these buyers less price-sensitive to the levy.
Why It Matters?
The med-à-terre is a window into two converging forces in high-net-worth wealth management. First, the growing recognition that healthcare access — specifically, access to the specific physicians who know your case history — is itself a form of wealth that cannot be easily relocated or replicated. Elite specialists at top-ranked oncology, cardiology, and orthopedic centers have long waitlists; the relationship capital built over decades cannot be transferred to a new city the way financial assets can. Second, it reveals that the pandemic-era urban exodus among the affluent was less permanent than it appeared: this cohort retained strong ties to New York’s ecosystem even as they changed their tax domicile. For New York’s luxury real estate market, it represents a durable demand segment that is relatively insulated from interest rate cycles and macroeconomic conditions — these buyers are motivated by healthcare continuity, not investment returns.
What’s Next?
Watch whether the new pied-à-terre tax — applying to second homes at $5 million and above — accelerates the trend toward the $2M–$4.9M tier, as buyers optimize to stay below the threshold while still achieving their medical-access goal. The real estate lobby warns the tax could soften the overall luxury market and accelerate high-net-worth departures; the countervailing force is that medical migration is a structural driver that tax policy alone is unlikely to eliminate. As the US population ages and elite medical institutions in a handful of cities (New York, Houston, Boston, Rochester/Minneapolis) consolidate their dominance, the med-à-terre phenomenon is likely to become a recognized real estate category rather than an anecdote — with implications for luxury condo demand in medical corridor neighborhoods nationwide.
Source: The Wall Street Journal
